Approvals/TGA/IRBESATZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack

Approved

STANDARD

IRBESATZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack

Sun Pharma ANZ Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: eacf5314fdf5c39e
Product Name: IRBESATZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack
Artg Id: 190462
Artg Name: IRBESATZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack
Sponsor: Sun Pharma ANZ Pty Ltd
Company Detail Path: /organization/sun-pharma-anz-pty-ltd
Artg Date: 2012-09-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

eacf5314fdf5c39e

Type

Standard